References
- Arbuthnott GW, Ingham CA. 1993. The thorny problem of what dopamine does in psychiatric disease. Prog Brain Res 99:341–350.
- Balcita-Pedicino JJ, Omelchenko N, Bell R, Sesack SR. 2011. The inhibitory influence of the lateral habenula on midbrain dopamine cells: ultrastructural evidence for indirect mediation via the rostromedial mesopontine tegmental nucleus. J Comp Neurol 519:1143–1164.
- Beaulieu JM, Gainetdinov RR. 2011. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63:182–217.
- Brinschwitz K, Dittgen A, Madai VI, Lommel R, Geisler S, Veh RW. 2010. Glutamatergic axons from the lateral habenula mainly terminate on GABAergic neurons of the ventral midbrain. Neuroscience 168:463–476.
- Bromberg-Martin SE, Matsumoto M, Hikosaka O. 2010. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 68:815–834.
- Ferreira JG, Del-Fava F, Hasue RH, Shammah-Lagnado SJ. 2008. Organization of ventral tegmental area projections to the ventral tegmental area-nigral complex in the rat. Neuroscience 153:196–213.
- Geisler S, Marinelli M, Degarmo B, Becker ML, Freiman AJ, Beales M, . 2008. Prominent activation of brainstem and pallidal afferents of the ventral tegmental area by cocaine. Neuropsychopharmacology 33:2688–2700.
- Grace AA, Floresco SB, Goto Y, Lodge DJ. 2007. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 30:220–227.
- Herkenham M, Nauta WJ. 1979. Efferent connections of the habenular nuclei in the rat. J Comp Neurol 187:19–47.
- Hikosaka O. 2010. The habenula: from stress evasion to value-based decision-making. Nat Rev Neurosci 11:503–513.
- Hikosaka O, Sesack SR, Lecourtier L, Shepard PD. 2008. Habenula: crossroad between the basal ganglia and the limbic system. J Neurosci 28:11825–11829.
- Holstege G. 2009. The mesopontine rostromedial tegmental nucleus and the emotional motor system: role in basic survival behavior. J Comp Neurol 513:559–565.
- Hong S, Hikosaka O. 2009. Negative reward signals from lateral habenula to dopamine neurons are mediated by a group of medial mesopontine neurons. 2009 Neuroscience Meeting Planner. Chicago, IL: Society for Neuroscience, Program No 482.6 online.
- Hong S, Jhou TC, Smith MK, Saleem KS, Hikosaka O. 2010. Rostromedial tegmental nucleus in primates mediates habenula-induced inhibitions of dopamine neurons: physiological and anatomical studies. 2010 Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience, Program No 916.15 online.
- Ikemoto S. 2007. Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev 56:27–78.
- Ikemoto S. 2010. Brain Reward circuitry beyond the mesolimbic dopamine system: a neurobiology theory. Neurosci Biobehav Rev 35:129–150.
- Iversen SD, Iversen LL. 2007. Dopamine: 50 years in perspective. Trends Neurosci 30:188–193.
- Jhou TC, Geisler S, Marinelli M, Degarmo BA, Zahm DS. 2009a. The mesopontine rostromedial tegmental nucleus: a structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta. J Comp Neurol 513:566–596.
- Jhou TC, Fields HL, Baxter MG, Saper CB, Holland PC. 2009b. The rostromedial tegmental nucleus (RMTg), a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses. Neuron 61:786–800.
- Kaufling J, Veinante P, Pawlowski SA, Freund-Mercier MJ, Barrot M. 2009. Afferents to the GABAergic tail of the ventral tegmental area in the rat. J Comp Neurol 513:597–621.
- Kaufling J, Veinante P, Pawlowski SA, Freund-Mercier MJ, Barrot M. 2010a. Gamma-aminobutyric acid cells with cocaine-induced DeltaFosB in the ventral tegmental area innervate mesolimbic neurons. Biol Psychiatry 67:88–92.
- Kaufling J, Waltisperger E, Bourdy R, Valera A, Veinante P, Freund-Mercier MJ, . 2010b. Pharmacological recruitment of the GABAergic tail of the ventral tegmental area by acute drug exposure. Br J Pharmacol 161:1677–1691.
- Le Moal M, Simon H. 1991. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev 71:155–234.
- Lecca S, Melis M, Luchicchi A, Ennas MG, Castelli MP, Muntoni AL, . 2011. Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells. Neuropsychopharmacology 36:589–602.
- Lehman J, Matheson R, Haber SN. 2010. Lateral habenula nucleus connectivity in the primate. 2010 Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience, Program No 511.17 online.
- Nestler EJ, Carlezon WA Jr. 2006. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59:1151–1159.
- Olson VG, Nestler EJ. 2007. Topographical organization of GABAergic neurons within the ventral tegmental area of the rat. Synapse 61:87–95.
- Paxinos G, Watson C. 2007. The rat brain in stereotaxic coordinates. 6th San Diego, CA: Academic Press (fig 89–92).
- Perrotti LI, Bolanos CA, Choi KH, Russo SJ, Edwards S, Ulery PG, . 2005. DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment. Eur J Neurosci 21:2817–2824.
- Sartorius A, Kiening KL, Kirsch P, von Gall CC, Haberkorn U, Unterberg AW, . 2010. Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient. Biol Psychiatry 67:e9–e11.
- Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS, . 2000. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 20:8620–8628.
- Schultz W. 2007. Behavioral dopamine signals. Trends Neurosci 30:203–210.
- Sesack SR, Grace AA. 2010. Cortico-basal ganglia reward network: microcircuitry. Neuropsychopharmacology 35:27–47.
- Sulzer D. 2011. How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69:628–649.
- Zahm DS, Becker ML, Freiman AJ, Strauch S, deGarmo B, Geisler S, . 2010. Fos after single and repeated self-administration of cocaine and saline in the rat: emphasis on the basal forebrain and recalibration of expression. Neuropsychopharmacology 35:445–463.